Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCompass Group Regulatory News (CPG)

Share Price Information for Compass Group (CPG)

Share Price is delayed by 15 minutes
Get Live Data
32.97    -0.01 (-0.03%)
Bid:
34.61
Ask:
31.08
Spread: -3.53 (-10.199%)
Market Cap: $56.06b
CPG Live PriceLast checked at - London Stock Exchange

Intraday Compass Group Share Chart

Share Buyback Programme

24 Jul 2023 07:00

RNS Number : 8761G
Compass Group PLC
24 July 2023
 

Legal Entity Identifier (LEI) No. 2138008M6MH9OZ6U2T68

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER FOR SALE OF ANY SECURITIES OR AN OFFER OR INVITATION TO PURCHASE ANY SECURITIES IN ANY JURISDICTION OR A SOLICITATION OF ANY VOTE OR APPROVAL.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

 

SHARE BUYBACK PROGRAMME

 

Compass Group PLC (the "Company") announces that on 21 July 2023 it entered into a non-discretionary agreement with Barclays Capital Securities Limited ("Barclays") to enable the purchase of up to £500 million of the Company's ordinary shares of 11 1/20 pence each ("Ordinary Shares") between 24 July 2023 and 14 November 2023. This follows the successful completion of a £250 million non-discretionary programme on 3 July 2023. Both programmes form the Company's £750 million share buyback programme announced with its half year results on 10 May 2023 (the "Programme").

 

The purpose of the Programme is to reduce the share capital of the Company by returning surplus capital to shareholders.

 

The Programme will be conducted within certain pre-set parameters. The Company's shareholders generally authorised it to purchase up to a maximum of 175,720,000 Ordinary Shares at its 2023 Annual General Meeting held on 9 February 2023, subject to certain limitations (the "General Authority"). The aggregate number of Ordinary Shares acquired by the Company pursuant to the Programme shall not exceed the maximum number of Ordinary Shares which the Company is authorised to purchase pursuant to the General Authority.

 

Barclays will make its trading decisions in relation to the Company's Ordinary Shares independently of, and uninfluenced by, the Company. In accordance with the General Authority, purchases of Ordinary Shares pursuant to the Programme may be conducted on any appropriate regulated stock market but will be on-sold by Barclays to the Company on the London Stock Exchange.

 

In addition to compliance with the terms of the General Authority, the Programme will also be conducted within the parameters prescribed by the Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), the Commission Delegated Regulation (EU) 2016/1052 (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) and in accordance with Chapter 12 of the UK Listing Rules.

 

All Ordinary Shares purchased will be held in treasury and are expected to be used to meet obligations arising from employee share schemes, or other allocations of shares, to employees or directors. No purchases will be made in respect of the Company's American Depositary Receipts.

 

Enquiries

 

Investors:

Agatha Donnelly & Helen Javanshiri

+44 (0) 1932 573 000

Press:

Giles Robinson

+44 (0) 1932 963 486

Website:

www.compass-group.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUOSVRONUBUAR
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
11th May 20267:00 amRNSHalf Year Results Announcement
1st May 20267:00 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSChange in trading currency of Ordinary Shares
1st Apr 20267:00 amRNSTotal Voting Rights
18th Mar 20267:00 amRNSChange in trading currency of Ordinary Shares
6th Mar 202610:15 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTotal Voting Rights
10th Feb 20262:00 pmRNSSterling Equivalent of Final Dividend
5th Feb 20262:42 pmRNSResult of AGM
5th Feb 20267:00 amRNSQ1 Trading Statement
2nd Feb 20267:00 amRNSTotal Voting Rights
20th Jan 202610:38 amRNSAnnual Financial Report 2025
15th Jan 202611:15 amRNSHolding(s) in Company
9th Jan 202611:45 amRNSDirector/PDMR Shareholding
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
17th Dec 202512:00 pmRNSAnnual Report 2025 and Notice of AGM 2026
8th Dec 20253:15 pmRNSDirector Declaration
5th Dec 20255:50 pmRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSTotal Voting Rights
25th Nov 20252:30 pmRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSFull Year Results
3rd Nov 20257:00 amRNSTotal Voting Rights
1st Oct 20257:05 amRNSTotal Voting Rights
1st Oct 20257:00 amRNSBlock listing Interim Review
26th Sep 20252:00 pmRNSBoard and Committee Changes
22nd Sep 20255:58 pmRNSHolding(s) in Company
12th Sep 20252:45 pmRNSDirector Declaration
1st Sep 20257:00 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTotal Voting Rights
22nd Jul 20257:00 amRNSQ3 Trading Update
22nd Jul 20257:00 amRNSCompass Group PLC agrees to acquire Vermaat Groep
15th Jul 20254:45 pmRNSSterling Equivalent of Interim Dividend
1st Jul 20257:00 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTotal Voting Rights
14th May 20257:00 amRNSHalf Year Results Announcement
1st May 20257:00 amRNSTotal Voting Rights
2nd Apr 20252:30 pmRNSDirector Declaration
1st Apr 20259:00 amRNSBlock listing Interim Review
1st Apr 20257:00 amRNSTotal Voting Rights
21st Mar 20254:25 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTotal Voting Rights
13th Feb 20254:00 pmRNSDirector/PDMR Shareholding
11th Feb 20253:00 pmRNSSterling Equivalent of Final Dividend
6th Feb 20254:41 pmRNSResult of AGM
6th Feb 20257:00 amRNSTrading Statement
3rd Feb 20257:00 amRNSTotal Voting Rights
28th Jan 202511:30 amRNSAnnual Financial Report
2nd Jan 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.